Page last updated: 2024-10-24

caffeine and Anochlesia

caffeine has been researched along with Anochlesia in 17 studies

Research Excerpts

ExcerptRelevanceReference
"HP produced a full blown catalepsy, akinesia and a significant impairment in locomotion and antioxidant status."1.48Interplay between adenosine receptor antagonist and cyclooxygenase inhibitor in haloperidol-induced extrapyramidal effects in mice. ( Anoopkumar-Dukie, S; Arora, D; Grant, GD; Hall, S; Kinra, M; Mallik, SB; Mudgal, J; Nampoothiri, M; Rao, CM, 2018)
"Epigallocatechin gallate (EGCG) is a major component of tea and its known interactions with caffeine make it worthwhile to further study them by investigating the influence of EGCG on the anticataleptic and locomotor-sensitizing effects of caffeine."1.42Tea component, epigallocatechin gallate, potentiates anticataleptic and locomotor-sensitizing effects of caffeine in mice. ( Acquas, E; Arote, S; Cotti, E; Gaikar, M; Kasture, SB; Kasture, V; Rosas, M; Salve, B, 2015)
"In order to assess whether caffeine and theophylline have the same potency and efficacy to reverse the impairment of motor function caused by acute or chronic interruption of striatal dopamine transmission, a comparison of their dose-response relationship was made in the acute model of haloperidol-induced catalepsy, and the chronic model of unilateral lesion of the dopamine nigrostriatal pathway with 6-hydroxydopamine."1.39Caffeine has greater potency and efficacy than theophylline to reverse the motor impairment caused by chronic but not acute interruption of striatal dopaminergic transmission in rats. ( Acuña-Lizama, MM; Alvarez-Cervera, FJ; Bata-García, JL; Góngora-Alfaro, JL, 2013)
"Haloperidol is a classical antipsychotic drug, which produces extra-pyrimidal Parkinson's symptoms (EPS)."1.35Antagonism of haloperidol-induced swim impairment in L-dopa and caffeine treated mice: a pre-clinical model to study Parkinson's disease. ( Barodia, SK; Luthra, PM; Raghubir, R, 2009)
"Treatment with caffeine significantly increased locomotion reduced by haloperidol, but not at all doses tested."1.35Adenosine antagonists reverse the cataleptic effects of haloperidol: implications for the treatment of Parkinson's disease. ( Goode, T; Harris, A; Trevitt, J; Vallance, C, 2009)
"Caffeine-treated rats also had higher catalepsy latency scores compared with control rats (P<0."1.35Long-lasting resistance to haloperidol-induced catalepsy in male rats chronically treated with caffeine. ( Alvarez-Cervera, FJ; Bata-García, JL; Góngora-Alfaro, JL; Heredia-López, FJ; Moo-Puc, RE; Pineda, JC; Villanueva-Toledo, JR, 2009)
"THP inhibited catalepsy intensity with an ED(50) of 0."1.32Caffeine and muscarinic antagonists act in synergy to inhibit haloperidol-induced catalepsy. ( Alvarez-Cervera, FJ; Arankowsky-Sandoval, G; Góngora-Alfaro, JL; Heredia-López, F; Moo-Puc, RE; Pineda, JC, 2003)
"Pretreatment with caffeine (25 mg/kg, IP, -10 min) blocked the inhibition of CAR produced by the adenosine agonists, suggesting the event is mediated via purinergic receptors."1.29Adenosine agonists reduce conditioned avoidance responding in the rat. ( Jarvis, MF; Martin, GE; Rossi, DJ, 1993)

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19904 (23.53)18.7374
1990's3 (17.65)18.2507
2000's7 (41.18)29.6817
2010's3 (17.65)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arora, D1
Mudgal, J1
Nampoothiri, M1
Mallik, SB1
Kinra, M1
Hall, S1
Anoopkumar-Dukie, S1
Grant, GD1
Rao, CM1
Kasture, SB1
Gaikar, M1
Kasture, V1
Arote, S1
Salve, B1
Rosas, M1
Cotti, E1
Acquas, E1
Varty, GB1
Hodgson, RA1
Pond, AJ1
Grzelak, ME1
Parker, EM1
Hunter, JC1
Luthra, PM1
Barodia, SK1
Raghubir, R1
Kasture, S1
Barhate, S1
Mohan, M1
Ballero, M1
Sanna, C1
Maxia, A1
Trevitt, J1
Vallance, C1
Harris, A1
Goode, T1
Góngora-Alfaro, JL3
Moo-Puc, RE2
Villanueva-Toledo, JR1
Alvarez-Cervera, FJ3
Bata-García, JL2
Heredia-López, FJ1
Pineda, JC2
Acuña-Lizama, MM1
Arankowsky-Sandoval, G1
Heredia-López, F1
Martin, GE1
Rossi, DJ1
Jarvis, MF1
Ward, RP1
Dorsa, DM1
Shiozaki, S1
Ichikawa, S1
Nakamura, J1
Kitamura, S1
Yamada, K1
Kuwana, Y1
Chen, JF1
Moratalla, R1
Impagnatiello, F1
Grandy, DK1
Cuellar, B1
Rubinstein, M1
Beilstein, MA1
Hackett, E1
Fink, JS1
Low, MJ1
Ongini, E1
Schwarzschild, MA1
Zetler, G1
Boissier, JR1
Simon, P1
Villeneuve, A1
Larousse, C1
Fog, R1
Marcus, RJ1
Winters, WD1
Roberts, E1
Simonsen, DG1

Reviews

1 review available for caffeine and Anochlesia

ArticleYear
On stereotypy and catalepsy: studies on the effect of amphetamines and neuroleptics in rats.
    Acta neurologica Scandinavica. Supplementum, 1972, Volume: 50

    Topics: Amphetamine; Animals; Basal Ganglia; Caffeine; Catalepsy; Cocaine; Compulsive Behavior; Corpus Stria

1972

Other Studies

16 other studies available for caffeine and Anochlesia

ArticleYear
Interplay between adenosine receptor antagonist and cyclooxygenase inhibitor in haloperidol-induced extrapyramidal effects in mice.
    Metabolic brain disease, 2018, Volume: 33, Issue:4

    Topics: Animals; Antipsychotic Agents; Basal Ganglia Diseases; Caffeine; Catalepsy; Cyclooxygenase Inhibitor

2018
Tea component, epigallocatechin gallate, potentiates anticataleptic and locomotor-sensitizing effects of caffeine in mice.
    Behavioural pharmacology, 2015, Volume: 26, Issue:1-2

    Topics: Animals; Antipsychotic Agents; Caffeine; Catalepsy; Catechin; Disease Models, Animal; Dose-Response

2015
The effects of adenosine A2A receptor antagonists on haloperidol-induced movement disorders in primates.
    Psychopharmacology, 2008, Volume: 200, Issue:3

    Topics: Adenosine A2 Receptor Antagonists; Animals; Antipsychotic Agents; Caffeine; Catalepsy; Cebus; Corpus

2008
Antagonism of haloperidol-induced swim impairment in L-dopa and caffeine treated mice: a pre-clinical model to study Parkinson's disease.
    Journal of neuroscience methods, 2009, Apr-15, Volume: 178, Issue:2

    Topics: Analysis of Variance; Animals; Antiparkinson Agents; Caffeine; Catalepsy; Corpus Striatum; Disease M

2009
Caffeine withdrawal retains anticataleptic activity but Withania somnifera withdrawal potentiates haloperidol-induced catalepsy in mice.
    Natural product research, 2009, Volume: 23, Issue:8

    Topics: Analysis of Variance; Animals; Caffeine; Catalepsy; Haloperidol; Mice; Nervous System; Plant Extract

2009
Adenosine antagonists reverse the cataleptic effects of haloperidol: implications for the treatment of Parkinson's disease.
    Pharmacology, biochemistry, and behavior, 2009, Volume: 92, Issue:3

    Topics: Animals; Caffeine; Catalepsy; Dose-Response Relationship, Drug; Haloperidol; Male; Parkinson Disease

2009
Long-lasting resistance to haloperidol-induced catalepsy in male rats chronically treated with caffeine.
    Neuroscience letters, 2009, Oct-09, Volume: 463, Issue:3

    Topics: Animals; Caffeine; Catalepsy; Central Nervous System Stimulants; Disease Susceptibility; Dopamine D2

2009
Caffeine has greater potency and efficacy than theophylline to reverse the motor impairment caused by chronic but not acute interruption of striatal dopaminergic transmission in rats.
    Neuropharmacology, 2013, Volume: 70

    Topics: Animals; Caffeine; Catalepsy; Corpus Striatum; Dopaminergic Neurons; Dose-Response Relationship, Dru

2013
Caffeine and muscarinic antagonists act in synergy to inhibit haloperidol-induced catalepsy.
    Neuropharmacology, 2003, Volume: 45, Issue:4

    Topics: Animals; Caffeine; Catalepsy; Dose-Response Relationship, Drug; Drug Synergism; Haloperidol; Male; M

2003
Adenosine agonists reduce conditioned avoidance responding in the rat.
    Pharmacology, biochemistry, and behavior, 1993, Volume: 45, Issue:4

    Topics: Adenosine; Animals; Antipsychotic Agents; Avoidance Learning; Binding, Competitive; Caffeine; Catale

1993
Molecular and behavioral effects mediated by Gs-coupled adenosine A2a, but not serotonin 5-Ht4 or 5-Ht6 receptors following antipsychotic administration.
    Neuroscience, 1999, Volume: 89, Issue:3

    Topics: Adenosine; Animals; Antipsychotic Agents; Behavior, Animal; Caffeine; Catalepsy; Clozapine; Corpus S

1999
Actions of adenosine A2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTP.
    Psychopharmacology, 1999, Volume: 147, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adenosine; Animals; Antiparkinson Agents; Antipsychoti

1999
The role of the D(2) dopamine receptor (D(2)R) in A(2A) adenosine receptor (A(2A)R)-mediated behavioral and cellular responses as revealed by A(2A) and D(2) receptor knockout mice.
    Proceedings of the National Academy of Sciences of the United States of America, 2001, Feb-13, Volume: 98, Issue:4

    Topics: Adenosine; Amphetamines; Animals; Caffeine; Catalepsy; Corpus Striatum; Dopamine Antagonists; Enkeph

2001
Drug-induced catalepsy as influenced by convulsant and anticonvulsant drugs.
    Neuropharmacology, 1973, Volume: 12, Issue:8

    Topics: Animals; Anticonvulsants; Arecoline; Bemegride; Caffeine; Catalepsy; Central Nervous System Stimulan

1973
Flurothyl in mice: seizure, post-convulsive behavior, and interactions with psychotropic drugs.
    Canadian journal of physiology and pharmacology, 1968, Volume: 46, Issue:1

    Topics: Amphetamine; Animals; Atropine; Behavior, Animal; Biperiden; Caffeine; Catalepsy; Central Nervous Sy

1968
Neuropharmacological studies of imidazole-4-acetic acid actions in the mouse and rat.
    Neuropharmacology, 1971, Volume: 10, Issue:21

    Topics: Acetates; Animals; Ataxia; Behavior; Caffeine; Catalepsy; Central Nervous System; Drug Interactions;

1971